Efficacy and Safety of Panax Notoginseng Saponins (Xueshuantong) in Patients With Acute Ischemic Stroke (EXPECT) Trial: Rationale and Design

• المؤلفون الرئيسيون: Luda Feng (مؤلف), Fang Han (مؤلف), Li Zhou (مؤلف), Shengxian Wu (مؤلف), Yawei Du (مؤلف), Dandan Zhang (مؤلف), Chi Zhang (مؤلف), Ying Gao (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: Although revascularization treatment is recommended as the first-line therapy for patients with non-minor acute ischemic stroke (AIS), it only benefits a minority of patients. Previous studies have reported the positive effects of Panax notoginseng saponins (PNS) (Xueshuantong lyophilize...